BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21798460)

  • 1. Do HPV vaccine genotypes agree with circulating HPV types?
    Tartaglia E; Iafusco D; Galderisi A; Mastrantonio P
    Lancet Infect Dis; 2011 Aug; 11(8):585-6. PubMed ID: 21798460
    [No Abstract]   [Full Text] [Related]  

  • 2. Genital HPV types in Australia.
    Brotherton J; Garland S; Donovan B
    Lancet Infect Dis; 2012 Feb; 12(2):102-3. PubMed ID: 22281139
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of herd immunity from human papillomavirus vaccination.
    Bogaards JA; Berkhof J
    Lancet Infect Dis; 2011 Dec; 11(12):896; author reply 896-7. PubMed ID: 22115067
    [No Abstract]   [Full Text] [Related]  

  • 4. The male HPV vaccine.
    O'Connor MB
    Ir Med J; 2009; 102(10):345. PubMed ID: 20108812
    [No Abstract]   [Full Text] [Related]  

  • 5. Promising control of genital warts: but is elimination possible?
    Lacey CJ; Garnett GP
    Lancet Infect Dis; 2011 Jan; 11(1):4-6. PubMed ID: 21183139
    [No Abstract]   [Full Text] [Related]  

  • 6. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
    Gertig DM; Brotherton JM; Saville M
    Sex Health; 2011 Jun; 8(2):171-8. PubMed ID: 21592430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bug breakfast in the bulletin: the early impact of the national HPV vaccination program.
    Quinn E; Donovan B; Sheppeard VK
    N S W Public Health Bull; 2012 Dec; 23(9-10):208. PubMed ID: 23442998
    [No Abstract]   [Full Text] [Related]  

  • 8. Real world effectiveness of population-based roll out of human papillomavirus vaccination against rates of genital warts.
    Smith JS; Weiderpass E
    J Natl Cancer Inst; 2013 Apr; 105(7):449-51. PubMed ID: 23486549
    [No Abstract]   [Full Text] [Related]  

  • 9. Human papillomavirus type-distribution in condylomata acuminata of mainland China: a meta-analysis.
    Wang H; Qiao YL
    Int J STD AIDS; 2008 Oct; 19(10):680-4. PubMed ID: 18824620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HPV vaccine controversy.
    Intlekofer KA; Cunningham MJ; Caplan AL
    Virtual Mentor; 2012 Jan; 14(1):39-49. PubMed ID: 23116916
    [No Abstract]   [Full Text] [Related]  

  • 11. Number of human papillomavirus vaccine doses and condyloma.
    Kreimer AR; Safaeian M; Hildesheim A
    JAMA; 2014 Jun; 311(23):2439. PubMed ID: 24938569
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of HPV immunization on the detection of cervical disease.
    Munro AJ; Cruickshank ME
    Expert Rev Vaccines; 2014 Apr; 13(4):533-44. PubMed ID: 24606579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of human papillomavirus vaccine doses and condyloma--reply.
    Ploner A; Herweijer E; Arnheim-Dahlström L
    JAMA; 2014 Jun; 311(23):2439-40. PubMed ID: 24938570
    [No Abstract]   [Full Text] [Related]  

  • 15. From the monovalent to the nine-valent HPV vaccine.
    Pils S; Joura EA
    Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine for the prevention of genital warts in males: profile report. demail@springer.com.
    Garnock-Jones KP; Giuliano AR
    Drugs R D; 2012 Dec; 12(4):235-8. PubMed ID: 23017129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing bivalent and quadrivalent HPV vaccines.
    Verheijen RH
    BMJ; 2011 Sep; 343():d5720. PubMed ID: 21951757
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for effectiveness of a national HPV vaccination programme: national prescription data from New Zealand.
    Wilson N; Morgan J; Baker MG
    Sex Transm Infect; 2014 Mar; 90(2):103. PubMed ID: 24526666
    [No Abstract]   [Full Text] [Related]  

  • 19. Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden.
    Herweijer E; Ploner A; Sparén P
    Vaccine; 2018 Apr; 36(15):1917-1920. PubMed ID: 29523448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 9-Valent human papillomavirus vaccine: a review of the clinical development program.
    Luxembourg A; Moeller E
    Expert Rev Vaccines; 2017 Nov; 16(11):1119-1139. PubMed ID: 28956458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.